TSF Incorporated
Data sourced from IRS 990 public filings
TSF Incorporated Research for treatment of Sanfilippo Syndrome Mission is to facilitate lab work and research needed to bring a treatment to trials for Sanfilippo Syndrome
Annual Revenue
$215,924
Known Funders
3
Grants Received
7
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $215,924 | $298,020 | $1,325,389 |
| 2023 | $183,778 | $210,729 | $1,407,485 |
| 2022 | $141,992 | $277,448 | $1,434,405 |
| 2021 | $216,212 | $273,824 | $1,569,861 |
| 2020 | $26,966 | $151,009 | $1,627,473 |
| 2019 | $185,245 | $726,228 | $1,819,816 |
| 2018 | $374,453 | $149,920 | $3,136,426 |
| 2017 | $4,965,846 | $4,129,985 | $5,891,728 |
Top Funders
WASHINGTON, DC
WASHINGTON, DC
WASHINGTON, DC
CHARLOTTE, NC
CHARLOTTE, NC
CHARLOTTE, NC
Key Personnel
From 2024 IRS 990 filing
Kathleen Buckley
President
Patty Taormino
Vice President
Carl Kapes
Secretary
Danielle O'Connor
Treasurer
Arleta Feldman
Board Member
Karina Klimentjeva
Board Member
Iris Dahl Gierga
Board Member
Rick Connor
Board Member
Raquel Zaldua
Board Member
Ann Kameka
Board Member
Frequently Asked Questions
Other Nonprofits in Delaware
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.